![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Period Ending: | 2023 31/12 |
2023 30/09 |
2023 30/06 |
2022 31/12 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2683.37 | 2683.37 | - | 2597.88 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 2325.51 | 2325.51 | - | 2369.71 | ||||||||||||||||||||||||||||||
Gross Profit | 357.86 | 357.86 | - | 228.17 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 2532.79 | 2532.79 | - | 2605.01 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 150.58 | 150.58 | - | -7.13 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | 23.68 | 23.68 | - | -2.02 | ||||||||||||||||||||||||||||||
Other, Net | -25.29 | -25.29 | - | 36.77 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 152.19 | 152.19 | - | -41.88 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 33.23 | 33.23 | - | 74.92 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 118.96 | 118.96 | - | -116.8 | ||||||||||||||||||||||||||||||
Minority Interest | 498.52 | 498.52 | 493.06 | 485.59 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 116.5 | 116.5 | - | -116.82 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | 116.5 | 116.5 | - | -116.82 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 116.5 | 116.5 | - | -116.82 | ||||||||||||||||||||||||||||||
Dilution Adjustment | 1.27 | 1.27 | - | -0.558 | ||||||||||||||||||||||||||||||
Diluted Net Income | 115.22 | 115.22 | - | -116.26 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 1150.39 | 1150.39 | - | 1162.61 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 0.1 | 0.1 | - | -0.1 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 0.074 | 0.074 | - | -0.015 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review